#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fibrosarcoma Muscular dystrophy Rhabdomyosarcoma Breast angiosarcoma Neoplasm Glioblastoma Mastocytosis Li-Fraumeni syndrome Pulmonary tuberculosis Multiple system atrophy Neuroendocrine carcinoma Cataract CDKL5 deficiency disorder Angiosarcoma Hepatocellular carcinoma More trials…

    Learn about Rare Diseases

    Turner’s syndrome – Basic Information Leiomyosarcoma recurrent Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Malignant fibrous histiocytoma – Basic Information Cystic fibrosis – Life with Disease Mucopolysaccharidosis II – Trials in Disease Sarcoma – Treatment Factor VIII deficiency Ocular melanoma – Treatment Retinitis pigmentosa More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5458514 Meloxicam Volrustomig Selatogrel Zidovudine Sodium Glycocholate Tebipenem Pivoxil Hydrobromide Insulin Aspart Nimorazole MOLNUPIRAVIR Cilastatin Pimozide Masitinib Calcifediol Pioglitazone Hydrochloride Cx-039776 Tramazoline Hydrochloride Donepezil Hydrochloride AMMONIUM (15N) CHLORIDE Magnesium Oxide, Light More therapies…

    Learn about Your Condition

    Pleural mesothelioma malignant Langerhans' cell histiocytosis Ataxia telangiectasia Hyperphagia Diabetic foot Autoimmune hepatitis Ichthyosis Ewing's sarcoma metastatic Strongyloidiasis Endotracheal intubation Lung adenocarcinoma stage III Burning mouth syndrome Corneal graft failure Type IIa hyperlipidaemia Bartonellosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Contact X-ray Brachytherapy with Capecitabine for Rectal Cancer Preservation in Adults with Intermediate Stage Rectal Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rectal adenocarcinoma
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    France

  • Study on Zanubrutinib and Rituximab for Patients with IgM Monoclonal Gammopathy and MAG Antibodies-Related Polyneuropathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anti-myelin-associated glycoprotein associated polyneuropathy
    Investigated Drugs:
    • Zanubrutinib
    The Netherlands

  • Study of Pembrolizumab and Chemotherapy for Patients with Locally Advanced Sinonasal Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nasal sinus cancer
    Investigated Drugs:
    • Pembrolizumab
    Italy

  • Study on the Use of Allogenic Adipose-Tissue-Derived Mesenchymal Stem Cells for Healing Chronic Digital Ulcers in Systemic Sclerosis Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    France

  • Study on Tranexamic Acid Oral Solution for Preventing Bleeding in Patients on Blood Thinners Undergoing Tooth Extraction

    Recruiting

    3 1
    Investigated Diseases:
    • Gingival bleeding
    • Haemorrhage prophylaxis
    Investigated Drugs:
    • Tranexamic Acid
    Croatia Hungary Romania Spain

  • Study on Montelukast for Slowing Parkinson’s Disease Progression in Patients with Mild to Moderate Symptoms

    Recruiting

    2 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Benserazide Hydrochloride
    • Montelukast Sodium
    • Levodopa
    Sweden
Previous Page
1 … 544 545 546 547 548 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!